Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 11 of 11 entries
Sorted by: Best Match Show Resources per page
Clinical Presentation of Uterine Fibroids in Nnewi, Nigeria: A 5-year Review.

Annals of medical and health sciences research

Ezeama C, Ikechebelu J, Obiechina Nj, Ezeama N.
PMID: 23440007
Ann Med Health Sci Res. 2012 Jul;2(2):114-8. doi: 10.4103/2141-9248.105656.

BACKGROUND: Uterine leiomyomas are the commonest benign tumors in women, with a higher preponderance amongst Africans. Several etiological factors have been suggested, with subtle variations in clinical presentation being reported in different studies. This may constitute a determinant for...

Cite
Ezeama C, Ikechebelu J, Obiechina Nj, et al. Clinical Presentation of Uterine Fibroids in Nnewi, Nigeria: A 5-year Review. Ann Med Health Sci Res. 2012;2(2):114-8doi: 10.4103/2141-9248.105656.
Ezeama, C., Ikechebelu, J., Obiechina, N. j., & Ezeama, N. (2012). Clinical Presentation of Uterine Fibroids in Nnewi, Nigeria: A 5-year Review. Annals of medical and health sciences research, 2(2), 114-8. https://doi.org/10.4103/2141-9248.105656
Ezeama, Co, et al. "Clinical Presentation of Uterine Fibroids in Nnewi, Nigeria: A 5-year Review." Annals of medical and health sciences research vol. 2,2 (2012): 114-8. doi: https://doi.org/10.4103/2141-9248.105656
Ezeama C, Ikechebelu J, Obiechina Nj, Ezeama N. Clinical Presentation of Uterine Fibroids in Nnewi, Nigeria: A 5-year Review. Ann Med Health Sci Res. 2012 Jul;2(2):114-8. doi: 10.4103/2141-9248.105656. PMID: 23440007; PMCID: PMC3573503.
Copy Download .nbib Format: NLM
Efficacy and safety of Syferol-IHP for the treatment of peptic ulcer disease: a pilot, double-blind randomized trial.

Clinical and experimental gastroenterology

Eleje GU, Ogbunugafor HA, Emegoakor CD, Okoye EI, Ezejiofor OI, Chukwurah SN, Ikechebelu JI, Nchinda GW, Ugochukwu CG, Nnaji-Ihedinmah LI, Okoye FBC, Eneh FU, Onwukamuche ME, Esimone CO.
PMID: 30679917
Clin Exp Gastroenterol. 2019 Jan 15;12:21-30. doi: 10.2147/CEG.S178179. eCollection 2019.

BACKGROUND: To our knowledge, there is no prior randomized study on the utility of Syferol-IHP (blend of virgin coconut oil and AIM: This study determined the efficacy and safety of Syferol-IHP as adjunct to conventional triple therapy for the...

Cite
Eleje GU, Ogbunugafor HA, Emegoakor CD, et al. Efficacy and safety of Syferol-IHP for the treatment of peptic ulcer disease: a pilot, double-blind randomized trial. Clin Exp Gastroenterol. 2019;12:21-30doi: 10.2147/CEG.S178179.
Eleje, G. U., Ogbunugafor, H. A., Emegoakor, C. D., Okoye, E. I., Ezejiofor, O. I., Chukwurah, S. N., Ikechebelu, J. I., Nchinda, G. W., Ugochukwu, C. G., Nnaji-Ihedinmah, L. I., Okoye, F. B. C., Eneh, F. U., Onwukamuche, M. E., & Esimone, C. O. (2019). Efficacy and safety of Syferol-IHP for the treatment of peptic ulcer disease: a pilot, double-blind randomized trial. Clinical and experimental gastroenterology, 1221-30. https://doi.org/10.2147/CEG.S178179
Eleje, George Uchenna, et al. "Efficacy and safety of Syferol-IHP for the treatment of peptic ulcer disease: a pilot, double-blind randomized trial." Clinical and experimental gastroenterology vol. 12 (2019): 21-30. doi: https://doi.org/10.2147/CEG.S178179
Eleje GU, Ogbunugafor HA, Emegoakor CD, Okoye EI, Ezejiofor OI, Chukwurah SN, Ikechebelu JI, Nchinda GW, Ugochukwu CG, Nnaji-Ihedinmah LI, Okoye FBC, Eneh FU, Onwukamuche ME, Esimone CO. Efficacy and safety of Syferol-IHP for the treatment of peptic ulcer disease: a pilot, double-blind randomized trial. Clin Exp Gastroenterol. 2019 Jan 15;12:21-30. doi: 10.2147/CEG.S178179. eCollection 2019. PMID: 30679917; PMCID: PMC6338118.
Copy Download .nbib Format: NLM
Fertility Outcomes following Laparoscopy-Assisted Hysteroscopic Fallopian Tube Cannulation: A Preliminary Study.

Obstetrics and gynecology international

Ikechebelu JI, Eleje GU, Bhamare P, Joe-Ikechebelu NN, Okafor CD, Akintobi AO.
PMID: 29977301
Obstet Gynecol Int. 2018 Jun 06;2018:7060459. doi: 10.1155/2018/7060459. eCollection 2018.

OBJECTIVES: To determine fertility outcomes following laparoscopy-guided hysteroscopic tubal cannulation for cornual obstruction.STUDY DESIGN: A prospective cohort study in Life Institute for Endoscopy at Life Specialist Hospital Nnewi, Southeast Nigeria. Patients with unilateral or bilateral cornual tubal obstruction as...

Cite
Ikechebelu JI, Eleje GU, Bhamare P, et al. Fertility Outcomes following Laparoscopy-Assisted Hysteroscopic Fallopian Tube Cannulation: A Preliminary Study. Obstet Gynecol Int. 2018;2018:7060459doi: 10.1155/2018/7060459.
Ikechebelu, J. I., Eleje, G. U., Bhamare, P., Joe-Ikechebelu, N. N., Okafor, C. D., & Akintobi, A. O. (2018). Fertility Outcomes following Laparoscopy-Assisted Hysteroscopic Fallopian Tube Cannulation: A Preliminary Study. Obstetrics and gynecology international, 20187060459. https://doi.org/10.1155/2018/7060459
Ikechebelu, Joseph I, et al. "Fertility Outcomes following Laparoscopy-Assisted Hysteroscopic Fallopian Tube Cannulation: A Preliminary Study." Obstetrics and gynecology international vol. 2018 (2018): 7060459. doi: https://doi.org/10.1155/2018/7060459
Ikechebelu JI, Eleje GU, Bhamare P, Joe-Ikechebelu NN, Okafor CD, Akintobi AO. Fertility Outcomes following Laparoscopy-Assisted Hysteroscopic Fallopian Tube Cannulation: A Preliminary Study. Obstet Gynecol Int. 2018 Jun 06;2018:7060459. doi: 10.1155/2018/7060459. eCollection 2018. PMID: 29977301; PMCID: PMC6011055.
Copy Download .nbib Format: NLM
Eight-hour versus 24-h urethral catheter removal following elective caesarean section for reducing significant bacteriuria: A randomized controlled trial.

Women's health (London, England)

Igbodike EP, Awowole IO, Kuti OO, Ajenifuja KO, Eleje GU, Olateju SO, Olopade BO, Ijarotimi OA, Irek EO, Igbodike NT, Ayegbusi OE, Ikechebelu JI, Okpala BC, Loto OM, Fehintola AO, Ajiboye AD, Fajobi O, Abuchi CS, Onwudiegwu UU, Fasubaa OB, Orji EO, Makinde ON, Owolabi AT, Adeyemi AB.
PMID: 34812114
Womens Health (Lond). 2021 Jan-Dec;17:17455065211060637. doi: 10.1177/17455065211060637.

BACKGROUND: There is no consensus on the preferred time to remove urethral catheter post caesarean section.AIM: To compare rate of significant bacteriuria and urinary retention following 8-h (study) and 24-h urethral catheter removal (control) post elective caesarean section.METHODS: A...

Cite
Igbodike EP, Awowole IO, Kuti OO, et al. Eight-hour versus 24-h urethral catheter removal following elective caesarean section for reducing significant bacteriuria: A randomized controlled trial. Womens Health (Lond). 2021;17:17455065211060637doi: 10.1177/17455065211060637.
Igbodike, E. P., Awowole, I. O., Kuti, O. O., Ajenifuja, K. O., Eleje, G. U., Olateju, S. O., Olopade, B. O., Ijarotimi, O. A., Irek, E. O., Igbodike, N. T., Ayegbusi, O. E., Ikechebelu, J. I., Okpala, B. C., Loto, O. M., Fehintola, A. O., Ajiboye, A. D., Fajobi, O., Abuchi, C. S., Onwudiegwu, U. U., Fasubaa, O. B., Orji, E. O., Makinde, O. N., Owolabi, A. T., & Adeyemi, A. B. (2021). Eight-hour versus 24-h urethral catheter removal following elective caesarean section for reducing significant bacteriuria: A randomized controlled trial. Women's health (London, England), 1717455065211060637. https://doi.org/10.1177/17455065211060637
Igbodike, Emeka Philip, et al. "Eight-hour versus 24-h urethral catheter removal following elective caesarean section for reducing significant bacteriuria: A randomized controlled trial." Women's health (London, England) vol. 17 (2021): 17455065211060637. doi: https://doi.org/10.1177/17455065211060637
Igbodike EP, Awowole IO, Kuti OO, Ajenifuja KO, Eleje GU, Olateju SO, Olopade BO, Ijarotimi OA, Irek EO, Igbodike NT, Ayegbusi OE, Ikechebelu JI, Okpala BC, Loto OM, Fehintola AO, Ajiboye AD, Fajobi O, Abuchi CS, Onwudiegwu UU, Fasubaa OB, Orji EO, Makinde ON, Owolabi AT, Adeyemi AB. Eight-hour versus 24-h urethral catheter removal following elective caesarean section for reducing significant bacteriuria: A randomized controlled trial. Womens Health (Lond). 2021 Jan-Dec;17:17455065211060637. doi: 10.1177/17455065211060637. PMID: 34812114; PMCID: PMC8628312.
Copy Download .nbib Format: NLM
Oxidative stress markers and lipid profiles of patients with polycystic ovary syndrome in a Nigerian tertiary hospital.

Obstetrics & gynecology science

Enechukwu CI, Onuegbu AJ, Olisekodiaka MJ, Eleje GU, Ikechebelu JI, Ugboaja JO, Amah UK, Okwara JE, Igwegbe AO.
PMID: 31538077
Obstet Gynecol Sci. 2019 Sep;62(5):335-343. doi: 10.5468/ogs.2019.62.5.335. Epub 2019 Aug 06.

OBJECTIVE: To determine the activities of oxidative stress markers and lipid profiles of patients with polycystic ovary syndrome (PCOS) in Nnamdi Azikiwe University Teaching Hospital Nnewi, Nigeria.METHODS: This was a nested case-control study consisting of 50 PCOS patients and...

Cite
Enechukwu CI, Onuegbu AJ, Olisekodiaka MJ, et al. Oxidative stress markers and lipid profiles of patients with polycystic ovary syndrome in a Nigerian tertiary hospital. Obstet Gynecol Sci. 2019;62(5):335-343doi: 10.5468/ogs.2019.62.5.335.
Enechukwu, C. I., Onuegbu, A. J., Olisekodiaka, M. J., Eleje, G. U., Ikechebelu, J. I., Ugboaja, J. O., Amah, U. K., Okwara, J. E., & Igwegbe, A. O. (2019). Oxidative stress markers and lipid profiles of patients with polycystic ovary syndrome in a Nigerian tertiary hospital. Obstetrics & gynecology science, 62(5), 335-343. https://doi.org/10.5468/ogs.2019.62.5.335
Enechukwu, Chukwunonso Isaiah, et al. "Oxidative stress markers and lipid profiles of patients with polycystic ovary syndrome in a Nigerian tertiary hospital." Obstetrics & gynecology science vol. 62,5 (2019): 335-343. doi: https://doi.org/10.5468/ogs.2019.62.5.335
Enechukwu CI, Onuegbu AJ, Olisekodiaka MJ, Eleje GU, Ikechebelu JI, Ugboaja JO, Amah UK, Okwara JE, Igwegbe AO. Oxidative stress markers and lipid profiles of patients with polycystic ovary syndrome in a Nigerian tertiary hospital. Obstet Gynecol Sci. 2019 Sep;62(5):335-343. doi: 10.5468/ogs.2019.62.5.335. Epub 2019 Aug 06. PMID: 31538077; PMCID: PMC6737061.
Copy Download .nbib Format: NLM
A double-blind placebo controlled trial on effectiveness of prophylactic dexamethasone for preventing post- dural puncture headache after spinal anesthesia for cesarean section.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Okpala BC, Eleje GU, Ikechebelu JI, Ofojebe CJ, Ejikeme TB, Nwachukwu CE, Okpala AN.
PMID: 32928014
J Matern Fetal Neonatal Med. 2020 Sep 14;1-6. doi: 10.1080/14767058.2020.1818719. Epub 2020 Sep 14.

AIM: To determine the effect of dexamethasone in reducing post-dural puncture headache (PDPH) after spinal anesthesia for cesarean section (CS).METHODS: A double blind placebo controlled randomized trial of parturients undergoing CS under spinal anesthesia was conducted. Participants (RESULTS: Baseline...

Cite
Okpala BC, Eleje GU, Ikechebelu JI, et al. A double-blind placebo controlled trial on effectiveness of prophylactic dexamethasone for preventing post- dural puncture headache after spinal anesthesia for cesarean section. J Matern Fetal Neonatal Med. 2020;1-6doi: 10.1080/14767058.2020.1818719.
Okpala, B. C., Eleje, G. U., Ikechebelu, J. I., Ofojebe, C. J., Ejikeme, T. B., Nwachukwu, C. E., & Okpala, A. N. (2020). A double-blind placebo controlled trial on effectiveness of prophylactic dexamethasone for preventing post- dural puncture headache after spinal anesthesia for cesarean section. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 1-6. https://doi.org/10.1080/14767058.2020.1818719
Okpala, Boniface Chukwuneme, et al. "A double-blind placebo controlled trial on effectiveness of prophylactic dexamethasone for preventing post- dural puncture headache after spinal anesthesia for cesarean section." The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians vol. (2020): 1-6. doi: https://doi.org/10.1080/14767058.2020.1818719
Okpala BC, Eleje GU, Ikechebelu JI, Ofojebe CJ, Ejikeme TB, Nwachukwu CE, Okpala AN. A double-blind placebo controlled trial on effectiveness of prophylactic dexamethasone for preventing post- dural puncture headache after spinal anesthesia for cesarean section. J Matern Fetal Neonatal Med. 2020 Sep 14;1-6. doi: 10.1080/14767058.2020.1818719. Epub 2020 Sep 14. PMID: 32928014.
Copy Download .nbib Format: NLM
Uterine leiomyomata causing tubal occlusion.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology

Ikechebelu JI, Onyejimbe UN.
PMID: 15512492
J Obstet Gynaecol. 2000 Jan;20(1):102. doi: 10.1080/01443610063714.

No abstract available.

Cite
Ikechebelu JI, Onyejimbe UN. Uterine leiomyomata causing tubal occlusion. J Obstet Gynaecol. 2000;20(1):102doi: 10.1080/01443610063714.
Ikechebelu, J. I., & Onyejimbe, U. N. (2000). Uterine leiomyomata causing tubal occlusion. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 20(1), 102. https://doi.org/10.1080/01443610063714
Ikechebelu, J I, and Onyejimbe, U N. "Uterine leiomyomata causing tubal occlusion." Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology vol. 20,1 (2000): 102. doi: https://doi.org/10.1080/01443610063714
Ikechebelu JI, Onyejimbe UN. Uterine leiomyomata causing tubal occlusion. J Obstet Gynaecol. 2000 Jan;20(1):102. doi: 10.1080/01443610063714. PMID: 15512492.
Copy Download .nbib Format: NLM
True umbilical cord knot leading to fetal demise.

Annals of medical and health sciences research

Ikechebelu J, Eleje G, Ofojebe C.
PMID: 25184085
Ann Med Health Sci Res. 2014 Jul;4:S155-8. doi: 10.4103/2141-9248.138044.

The incidence of true knot of the umbilical cord is not only very low but it is often undiagnosed antenatally when present despite the availability of prenatal ultrasonography. When the true knot remains tight, it may impede the circulation...

Cite
Ikechebelu J, Eleje G, Ofojebe C. True umbilical cord knot leading to fetal demise. Ann Med Health Sci Res. 2014;4:S155-8doi: 10.4103/2141-9248.138044.
Ikechebelu, J., Eleje, G., & Ofojebe, C. (2014). True umbilical cord knot leading to fetal demise. Annals of medical and health sciences research, 4S155-8. https://doi.org/10.4103/2141-9248.138044
Ikechebelu, Ji, et al. "True umbilical cord knot leading to fetal demise." Annals of medical and health sciences research vol. 4 (2014): S155-8. doi: https://doi.org/10.4103/2141-9248.138044
Ikechebelu J, Eleje G, Ofojebe C. True umbilical cord knot leading to fetal demise. Ann Med Health Sci Res. 2014 Jul;4:S155-8. doi: 10.4103/2141-9248.138044. PMID: 25184085; PMCID: PMC4145515.
Copy Download .nbib Format: NLM
Comparative study on the adequacy of cervical smears using wooden Ayre's spatula, VS Papcone® sampling device.

Gynecologic oncology reports

Enechukwu CI, Adinma JIB, Ikechebelu JI, Onyiaorah IV, Onwusulu DN, Chiemeka ME, Eleje GU, Ugboaja JO, Ezebialu IU, Ezenwa OB, Nwosu BO, Eke NO, Osakwe CR.
PMID: 34632035
Gynecol Oncol Rep. 2021 Sep 17;38:100860. doi: 10.1016/j.gore.2021.100860. eCollection 2021 Nov.

This is a comparative study on the adequacy of cervical smears obtained using the Papcone® sampling device or wooden Ayre's spatula conducted from two tertiary health facilities -- Nnamdi Azikiwe University Teaching Hospital Nnewi and Chukwuemeka Odumegwu Ojukwu University...

Cite
Enechukwu CI, Adinma JIB, Ikechebelu JI, et al. Comparative study on the adequacy of cervical smears using wooden Ayre's spatula, VS Papcone® sampling device. Gynecol Oncol Rep. 2021;38:100860doi: 10.1016/j.gore.2021.100860.
Enechukwu, C. I., Adinma, J. I. B., Ikechebelu, J. I., Onyiaorah, I. V., Onwusulu, D. N., Chiemeka, M. E., Eleje, G. U., Ugboaja, J. O., Ezebialu, I. U., Ezenwa, O. B., Nwosu, B. O., Eke, N. O., & Osakwe, C. R. (2021). Comparative study on the adequacy of cervical smears using wooden Ayre's spatula, VS Papcone® sampling device. Gynecologic oncology reports, 38100860. https://doi.org/10.1016/j.gore.2021.100860
Enechukwu, Chukwunonso Isaiah, et al. "Comparative study on the adequacy of cervical smears using wooden Ayre's spatula, VS Papcone® sampling device." Gynecologic oncology reports vol. 38 (2021): 100860. doi: https://doi.org/10.1016/j.gore.2021.100860
Enechukwu CI, Adinma JIB, Ikechebelu JI, Onyiaorah IV, Onwusulu DN, Chiemeka ME, Eleje GU, Ugboaja JO, Ezebialu IU, Ezenwa OB, Nwosu BO, Eke NO, Osakwe CR. Comparative study on the adequacy of cervical smears using wooden Ayre's spatula, VS Papcone® sampling device. Gynecol Oncol Rep. 2021 Sep 17;38:100860. doi: 10.1016/j.gore.2021.100860. eCollection 2021 Nov. PMID: 34632035; PMCID: PMC8487021.
Copy Download .nbib Format: NLM
Pregnant women's hepatitis B vaccination coverage in Nigeria: a national pilot cross-sectional study.

Therapeutic advances in vaccines and immunotherapy

Eleje GU, Akaba GO, Mbachu II, Rabiu A, Loto OM, Usman HA, Fiebai PO, Chukwuanukwu RC, Joe-Ikechebelu NN, Nwankwo CH, Kalu SO, Onubogu CU, Ogbuagu CN, Chukwurah SN, Uzochukwu CE, Inuyomi SO, Adesoji BA, Ogwaluonye UC, Nweje SI, Egeonu RO, Igue OE, Jibuaku CH, Aja PO, Chidozie CP, Ibrahim HS, Aliyu FE, Numan AI, Okoro OD, Omoruyi SA, Oppah IC, Anyang UI, Ahmed A, Umeononihu OS, Umeh EO, Emeka EA, Onwuegbuna AA, Igbodike EP, Ajuba IC, Yakasai IA, Ezechi OC, Ikechebelu JI.
PMID: 34377929
Ther Adv Vaccines Immunother. 2021 Jul 29;9:25151355211032595. doi: 10.1177/25151355211032595. eCollection 2021.

OBJECTIVE: To determine the hepatitis B vaccination coverage, full-dose (⩾3) coverage and the associated factors affecting uptake among pregnant women.METHODS: This was a cross-sectional study among pregnant women attending antenatal care in six tertiary hospitals across all the geopolitical...

Cite
Eleje GU, Akaba GO, Mbachu II, et al. Pregnant women's hepatitis B vaccination coverage in Nigeria: a national pilot cross-sectional study. Ther Adv Vaccines Immunother. 2021;9:25151355211032595doi: 10.1177/25151355211032595.
Eleje, G. U., Akaba, G. O., Mbachu, I. I., Rabiu, A., Loto, O. M., Usman, H. A., Fiebai, P. O., Chukwuanukwu, R. C., Joe-Ikechebelu, N. N., Nwankwo, C. H., Kalu, S. O., Onubogu, C. U., Ogbuagu, C. N., Chukwurah, S. N., Uzochukwu, C. E., Inuyomi, S. O., Adesoji, B. A., Ogwaluonye, U. C., Nweje, S. I., Egeonu, R. O., Igue, O. E., Jibuaku, C. H., Aja, P. O., Chidozie, C. P., Ibrahim, H. S., Aliyu, F. E., Numan, A. I., Okoro, O. D., Omoruyi, S. A., Oppah, I. C., Anyang, U. I., Ahmed, A., Umeononihu, O. S., Umeh, E. O., Emeka, E. A., Onwuegbuna, A. A., Igbodike, E. P., Ajuba, I. C., Yakasai, I. A., Ezechi, O. C., Ikechebelu, J. I. (2021). Pregnant women's hepatitis B vaccination coverage in Nigeria: a national pilot cross-sectional study. Therapeutic advances in vaccines and immunotherapy, 925151355211032595. https://doi.org/10.1177/25151355211032595
Eleje, George Uchenna, et al. "Pregnant women's hepatitis B vaccination coverage in Nigeria: a national pilot cross-sectional study." Therapeutic advances in vaccines and immunotherapy vol. 9 (2021): 25151355211032595. doi: https://doi.org/10.1177/25151355211032595
Eleje GU, Akaba GO, Mbachu II, Rabiu A, Loto OM, Usman HA, Fiebai PO, Chukwuanukwu RC, Joe-Ikechebelu NN, Nwankwo CH, Kalu SO, Onubogu CU, Ogbuagu CN, Chukwurah SN, Uzochukwu CE, Inuyomi SO, Adesoji BA, Ogwaluonye UC, Nweje SI, Egeonu RO, Igue OE, Jibuaku CH, Aja PO, Chidozie CP, Ibrahim HS, Aliyu FE, Numan AI, Okoro OD, Omoruyi SA, Oppah IC, Anyang UI, Ahmed A, Umeononihu OS, Umeh EO, Emeka EA, Onwuegbuna AA, Igbodike EP, Ajuba IC, Yakasai IA, Ezechi OC, Ikechebelu JI. Pregnant women's hepatitis B vaccination coverage in Nigeria: a national pilot cross-sectional study. Ther Adv Vaccines Immunother. 2021 Jul 29;9:25151355211032595. doi: 10.1177/25151355211032595. eCollection 2021. PMID: 34377929; PMCID: PMC8327013.
Copy Download .nbib Format: NLM
Delayed presentation of giant uterine fibroids in a Nigerian private specialist health facility.

SAGE open medical case reports

Ikechebelu JI, Okpala BC, Eleje GU, Nwachukwu CE, Nwajiaku LA, Nnoruka M.
PMID: 34881044
SAGE Open Med Case Rep. 2021 Dec 02;9:2050313X211063137. doi: 10.1177/2050313X211063137. eCollection 2021.

Giant uterine fibroids (leiomyoma or myomas) which are fibroid masses greater than 11.4 kg are very rare. Although benign in nature, it may present with symptoms that impact negatively on the quality of life and health of the patient...

Cite
Ikechebelu JI, Okpala BC, Eleje GU, et al. Delayed presentation of giant uterine fibroids in a Nigerian private specialist health facility. SAGE Open Med Case Rep. 2021;9:2050313X211063137doi: 10.1177/2050313X211063137.
Ikechebelu, J. I., Okpala, B. C., Eleje, G. U., Nwachukwu, C. E., Nwajiaku, L. A., & Nnoruka, M. (2021). Delayed presentation of giant uterine fibroids in a Nigerian private specialist health facility. SAGE open medical case reports, 92050313X211063137. https://doi.org/10.1177/2050313X211063137
Ikechebelu, Joseph Ifeanyichukwu, et al. "Delayed presentation of giant uterine fibroids in a Nigerian private specialist health facility." SAGE open medical case reports vol. 9 (2021): 2050313X211063137. doi: https://doi.org/10.1177/2050313X211063137
Ikechebelu JI, Okpala BC, Eleje GU, Nwachukwu CE, Nwajiaku LA, Nnoruka M. Delayed presentation of giant uterine fibroids in a Nigerian private specialist health facility. SAGE Open Med Case Rep. 2021 Dec 02;9:2050313X211063137. doi: 10.1177/2050313X211063137. eCollection 2021. PMID: 34881044; PMCID: PMC8646825.
Copy Download .nbib Format: NLM
Showing 1 to 11 of 11 entries